Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer

Platinum-based chemotherapy remains the cornerstone of treatment for most people with non-small cell lung cancer (NSCLC), either as adjuvant therapy in combination with a second cytotoxic agent or in combination with immunotherapy. Resistance to therapy, either in the form of primary refractory dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Sarah-Louise, Dave, Keyur A., Beard, Sam, Gyimesi, Martina, McTaggart, Matthew, Sahin, Katherine B., Molloy, Christopher, Gandhi, Neha S., Boittier, Eric, O’Leary, Connor G., Shah, Esha T., Bolderson, Emma, Baird, Anne-Marie, Richard, Derek J., O’Byrne, Kenneth J., Adams, Mark N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991912/
https://www.ncbi.nlm.nih.gov/pubmed/33777753
http://dx.doi.org/10.3389/fonc.2021.615967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991912/
https://www.ncbi.nlm.nih.gov/pubmed/33777753
http://dx.doi.org/10.3389/fonc.2021.615967

Ejemplares similares